Antibiotic use for asymptomatic bacteriuria in children with neurogenic bladder.
Document Type
Article
Publication Date
2022
Identifier
DOI: 10.3233/PRM-210051
Abstract
PURPOSE: Patients with neurogenic bladder (NB) often perform clean intermittent catheterization (CIC) and are predisposed to bladder colonization. Antibiotics are not routinely indicated in those with asymptomatic bacteriuria (ASB). The original purpose of this study was to compare patients that received antibiotics for ASB and those that did not. However, because the non-antibiotic group was very small, the final analysis evaluated treatment patterns of ASB in children with NB.
METHODS: A retrospective chart review was completed, including patients who presented with urinary tract infection (UTI) and NB managed by CIC. Patients with symptoms of UTI were excluded. Basic demographics, urinalysis, culture results, and antibiotic prescriptions were collected.
RESULTS: The sample included 272 patient encounters for 109 unique patients. Of these, 50.7% were female, and the median age was 10.25 years. More than half the urine cultures (56.2%) grew gram-negative organisms, and 31.3% contained 2 or more organisms. Nearly all encounters received treatment with antibiotics. Twenty-three encounters with no culture performed or the culture resulted in no growth received antibiotic therapy.
CONCLUSIONS: Antibiotic resistance and antibiotic stewardship are primary concerns in healthcare today. This organization's current practice pattern shows high antibiotic use for ASB in patients with NB. Future studies are required to identify outcomes associated with treatment versus non-treatment in these patients.
Journal Title
J Pediatr Rehabil Med
Volume
15
Issue
4
First Page
633
Last Page
638
Keywords
Urinary bladder; antimicrobial stewardship; bacteriuria; neurogenic; spinal dysraphism; urinary catheterization
Recommended Citation
Wickham A, McElroy SF, Austenfeld L, et al. Antibiotic use for asymptomatic bacteriuria in children with neurogenic bladder. J Pediatr Rehabil Med. 2022;15(4):633-638. doi:10.3233/PRM-210051